chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Hypersensitivity, Lymphadenopathy, Throat irritation, Urticaria
Clinical narrative: Minor swollen lymph nodes; A slightly itchy throat; Hives on neck and chest.; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: EW0150) via an unspecified route of administration in the left arm on 31Mar2021 at 10:15 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to pollen, latex, dander/dust and smoke. The patient did not receive any concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 12:15, the patient experienced minor swollen lymph nodes, a slightly itchy throat and hives on neck and chest. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events minor swollen lymph nodes, a slightly itchy throat and hives on neck and chest was recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lymphadenopathy, Throat irritation, Urticaria
Clinical narrative: Minor swollen lymph nodes; A slightly itchy throat; Hives on neck and chest.; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: EW0150) via an unspecified route of administration in the left arm on 31Mar2021 at 10:15 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to pollen, latex, dander/dust and smoke. The patient did not receive any concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 12:15, the patient experienced minor swollen lymph nodes, a slightly itchy throat and hives on neck and chest. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events minor swollen lymph nodes, a slightly itchy throat and hives on neck and chest was recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood pressure increased, Hyperacusis, Joint swelling, Lip swelling, Mouth swelling
Clinical narrative: Elevated blood pressure; swelling in mouth/lips; Nausea; Sensitivity to sound; Severe itching (all over, especially legs, thighs back, arms, scalp, eyebrows and in nostrils); This is a spontaneous report from a contactable consumer, the patient. A 77-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 0140), via an unspecified route of administration in the left arm on 20Jan2021 at 10:00 (at the age of 77-years-old), as a single dose for COVID-19 immunisation. Medical history included spinal stenosis, degenerative disc disease, arthritis, sciatica, high blood pressure, diabetes, high cholesterol, pollen allergy, dust allergy, ragweed allergy, carageenan allergy and fruit allergy (tomatoes). Concomitant medications included morphine sulfate (MANUFACTURER UNKNOWN), amlodipine (MANUFACTURER UNKNOWN) and metoprolol succinate (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications. The patient previously took simvastatin on unknown date for an unspecified indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Jan2021 at 22:00, the patient experienced swelling in mouth/lips, severe itching (all over, especially legs, thighs back, arms, scalp, eyebrows and in nostrils), nausea, sensitivity to sound and elevated blood pressure. It was unknown if therapeutic measures were taken as a result of the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events swelling in mouth/lips, severe itching (all over, especially legs, thighs back, arms, scalp, eyebrows and in nostrils), nausea, sensitivity to sound and elevated blood pressure were resolved on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Pruritus
Clinical narrative: Elevated blood pressure; swelling in mouth/lips; Nausea; Sensitivity to sound; Severe itching (all over, especially legs, thighs back, arms, scalp, eyebrows and in nostrils); This is a spontaneous report from a contactable consumer, the patient. A 77-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 0140), via an unspecified route of administration in the left arm on 20Jan2021 at 10:00 (at the age of 77-years-old), as a single dose for COVID-19 immunisation. Medical history included spinal stenosis, degenerative disc disease, arthritis, sciatica, high blood pressure, diabetes, high cholesterol, pollen allergy, dust allergy, ragweed allergy, carageenan allergy and fruit allergy (tomatoes). Concomitant medications included morphine sulfate (MANUFACTURER UNKNOWN), amlodipine (MANUFACTURER UNKNOWN) and metoprolol succinate (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications. The patient previously took simvastatin on unknown date for an unspecified indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Jan2021 at 22:00, the patient experienced swelling in mouth/lips, severe itching (all over, especially legs, thighs back, arms, scalp, eyebrows and in nostrils), nausea, sensitivity to sound and elevated blood pressure. It was unknown if therapeutic measures were taken as a result of the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events swelling in mouth/lips, severe itching (all over, especially legs, thighs back, arms, scalp, eyebrows and in nostrils), nausea, sensitivity to sound and elevated blood pressure were resolved on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood pressure increased, Hyperacusis, Mouth swelling, Nausea, Pruritus
Clinical narrative: Elevated blood pressure; swelling in mouth/lips; Nausea; Sensitivity to sound; Severe itching (all over, especially legs, thighs back, arms, scalp, eyebrows and in nostrils); This is a spontaneous report from a contactable consumer, the patient. A 77-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 0140), via an unspecified route of administration in the left arm on 20Jan2021 at 10:00 (at the age of 77-years-old), as a single dose for COVID-19 immunisation. Medical history included spinal stenosis, degenerative disc disease, arthritis, sciatica, high blood pressure, diabetes, high cholesterol, pollen allergy, dust allergy, ragweed allergy, carageenan allergy and fruit allergy (tomatoes). Concomitant medications included morphine sulfate (MANUFACTURER UNKNOWN), amlodipine (MANUFACTURER UNKNOWN) and metoprolol succinate (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications. The patient previously took simvastatin on unknown date for an unspecified indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Jan2021 at 22:00, the patient experienced swelling in mouth/lips, severe itching (all over, especially legs, thighs back, arms, scalp, eyebrows and in nostrils), nausea, sensitivity to sound and elevated blood pressure. It was unknown if therapeutic measures were taken as a result of the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events swelling in mouth/lips, severe itching (all over, especially legs, thighs back, arms, scalp, eyebrows and in nostrils), nausea, sensitivity to sound and elevated blood pressure were resolved on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Headache, Pain, Pyrexia, SARS-CoV-2 test negative
Clinical narrative: Fever 100.4-101.7; Headache; Muscle aches/pains for 10 days now constant; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 27Mar2021 at 12:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included  high blood pressure and asthmatic symptoms. The patient had no known allergies to medications, food, or other products. Concomitant medications included amlodipine (MANUFACTURER UNKNOWN), gabapentin (MANUFACTURER UNKNOWN), buspirone hydrochloride (BUSPAR), vortioxetine hydrobromide (TRINTELLIX) and estradiol (ESTROGEN); all from unknown dates for unknown indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number:UNKNOWN) via an unspecified route of administration in the left arm on 05Mar2021 at 12:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021 at 20:30, the patient experienced fever 100.4-101.7, headache and muscle aches/pains for 10 days now constant. On 27Mar2021, the body temperature was reported as 100.4-101.7 (unit unspecified). The events resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care visit. The patient did not receive any treatment for the events. On 03Apr2021, the patient underwent nasal swab test to rule out COVID and tested negative. On an unknown date, the patient underwent lab tests to rule out flu and urinary track infection (UTI) etc. and all tests were negative. The clinical outcome of the events fever 100.4-101.7, headache and muscle aches/pains was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Body temperature, Headache, Myalgia, Pyrexia
Clinical narrative: Fever 100.4-101.7; Headache; Muscle aches/pains for 10 days now constant; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 27Mar2021 at 12:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included  high blood pressure and asthmatic symptoms. The patient had no known allergies to medications, food, or other products. Concomitant medications included amlodipine (MANUFACTURER UNKNOWN), gabapentin (MANUFACTURER UNKNOWN), buspirone hydrochloride (BUSPAR), vortioxetine hydrobromide (TRINTELLIX) and estradiol (ESTROGEN); all from unknown dates for unknown indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number:UNKNOWN) via an unspecified route of administration in the left arm on 05Mar2021 at 12:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021 at 20:30, the patient experienced fever 100.4-101.7, headache and muscle aches/pains for 10 days now constant. On 27Mar2021, the body temperature was reported as 100.4-101.7 (unit unspecified). The events resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care visit. The patient did not receive any treatment for the events. On 03Apr2021, the patient underwent nasal swab test to rule out COVID and tested negative. On an unknown date, the patient underwent lab tests to rule out flu and urinary track infection (UTI) etc. and all tests were negative. The clinical outcome of the events fever 100.4-101.7, headache and muscle aches/pains was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test, Urine analysis
Clinical narrative: Fever 100.4-101.7; Headache; Muscle aches/pains for 10 days now constant; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 27Mar2021 at 12:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included  high blood pressure and asthmatic symptoms. The patient had no known allergies to medications, food, or other products. Concomitant medications included amlodipine (MANUFACTURER UNKNOWN), gabapentin (MANUFACTURER UNKNOWN), buspirone hydrochloride (BUSPAR), vortioxetine hydrobromide (TRINTELLIX) and estradiol (ESTROGEN); all from unknown dates for unknown indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number:UNKNOWN) via an unspecified route of administration in the left arm on 05Mar2021 at 12:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021 at 20:30, the patient experienced fever 100.4-101.7, headache and muscle aches/pains for 10 days now constant. On 27Mar2021, the body temperature was reported as 100.4-101.7 (unit unspecified). The events resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care visit. The patient did not receive any treatment for the events. On 03Apr2021, the patient underwent nasal swab test to rule out COVID and tested negative. On an unknown date, the patient underwent lab tests to rule out flu and urinary track infection (UTI) etc. and all tests were negative. The clinical outcome of the events fever 100.4-101.7, headache and muscle aches/pains was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Oropharyngeal pain, Rash
Clinical narrative: Starting at nighttime, I noticed an allergic feeling in my throat, it was minor. I only had a bit of a sore arm up until that point as far as I can remember. I reported all of this to the clinic . After that, I noticed platelets moving in the right side of my neck, platelets moving around in my chest, either lungs or heart, it felt like veins in my legs were collapsing and bruising from the inside, and about 3 toes on my left foot would feel completely dead while the other half of my foot cramped up for hours. It went on for well over a week, probably closer to two weeks.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Muscle spasms, Pain in extremity, Sensory disturbance, Throat irritation
Clinical narrative: Starting at nighttime, I noticed an allergic feeling in my throat, it was minor. I only had a bit of a sore arm up until that point as far as I can remember. I reported all of this to the clinic . After that, I noticed platelets moving in the right side of my neck, platelets moving around in my chest, either lungs or heart, it felt like veins in my legs were collapsing and bruising from the inside, and about 3 toes on my left foot would feel completely dead while the other half of my foot cramped up for hours. It went on for well over a week, probably closer to two weeks.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Pyrexia, Vomiting
Clinical narrative: Nausea and vomiting for 3 days. Dizziness; body ache; headache; mild congestion for 5-6 days.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Headache, Nausea, Pain, Respiratory tract congestion
Clinical narrative: Nausea and vomiting for 3 days. Dizziness; body ache; headache; mild congestion for 5-6 days.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vomiting
Clinical narrative: Nausea and vomiting for 3 days. Dizziness; body ache; headache; mild congestion for 5-6 days.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Fatigue, Oxygen saturation decreased
Clinical narrative: Patient had an ED visit and/or hospitalization within 6 weeks of receiving COVID vaccine.
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: Patient had an ED visit and/or hospitalization within 6 weeks of receiving COVID vaccine.
Age: 26.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Back pain, Blood test, Central nervous system lesion, Coordination abnormal, Demyelination
Clinical narrative: March 20 2021 (shortly after 2nd Pfizer COVID19 vaccine March 17 2021, injected into LEFT arm): woke up with burning, throbbing, RIGHT neck, shoulder, RIGHT  arm pain for 3-4 hours -- > numbness/tingling RIGHT shoulder to fingertips; dysesthesias to extremes of temperature in RIGHT arm; RIGHT hand>arm weakness and dexterity issues; dizziness with fast lateral movements that occurred a little bit later Pain went away in a few days, but still has residual numbness and tingling (even now) Dysesthesias to temperature lasted a few weeks   -- > MRI brain noncontrast March 29 2021 showed lesions c/f MS in the supra and infratentorium   -March 30 2021: L'hermitte's sign (shock or vibration) from abdomen to feet when looking down -- > steroids not given initially, as sx on neuro exam felt to be mild   -- > MRI C/T spine April 21 2021 with RIGHT C2-C3 nonenhancing lesion; repeat brain showed no enhancement -- > ACE slightly elevated; CT chest without LAN -- > April 23 2021 decided to order IV steroids given mild RIGHT hand weakness, given April 27-29 2021 -- helped, but still has numbness and tingling; it's getting easier to write and use a pipetter, but still some difficulty  IMPRESSION: This is a 26 Y man with CIS, one neurological event mostly causing RIGHT hand weakness and sensory sx plus vertigo that happened 3 days after a 2nd COVID19 vaccine.  He meets criteria for dissemination in space (spine, brainstem, and PV lesions) but does not meet dissemination in time (no contrast enhancing lesions, no change in brain lesions over 1 month of monitoring).  A LP is required to finalized criteria to discriminate between CIS and RRMS. Elevated ACE and ANA are common to see in MS, and I do not think they point to further pathology.
Age: 26.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Intervertebral disc disorder, Magnetic resonance imaging abnormal, Mobility decreased, Multiple sclerosis
Clinical narrative: March 20 2021 (shortly after 2nd Pfizer COVID19 vaccine March 17 2021, injected into LEFT arm): woke up with burning, throbbing, RIGHT neck, shoulder, RIGHT  arm pain for 3-4 hours -- > numbness/tingling RIGHT shoulder to fingertips; dysesthesias to extremes of temperature in RIGHT arm; RIGHT hand>arm weakness and dexterity issues; dizziness with fast lateral movements that occurred a little bit later Pain went away in a few days, but still has residual numbness and tingling (even now) Dysesthesias to temperature lasted a few weeks   -- > MRI brain noncontrast March 29 2021 showed lesions c/f MS in the supra and infratentorium   -March 30 2021: L'hermitte's sign (shock or vibration) from abdomen to feet when looking down -- > steroids not given initially, as sx on neuro exam felt to be mild   -- > MRI C/T spine April 21 2021 with RIGHT C2-C3 nonenhancing lesion; repeat brain showed no enhancement -- > ACE slightly elevated; CT chest without LAN -- > April 23 2021 decided to order IV steroids given mild RIGHT hand weakness, given April 27-29 2021 -- helped, but still has numbness and tingling; it's getting easier to write and use a pipetter, but still some difficulty  IMPRESSION: This is a 26 Y man with CIS, one neurological event mostly causing RIGHT hand weakness and sensory sx plus vertigo that happened 3 days after a 2nd COVID19 vaccine.  He meets criteria for dissemination in space (spine, brainstem, and PV lesions) but does not meet dissemination in time (no contrast enhancing lesions, no change in brain lesions over 1 month of monitoring).  A LP is required to finalized criteria to discriminate between CIS and RRMS. Elevated ACE and ANA are common to see in MS, and I do not think they point to further pathology.
Age: 26.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia
Clinical narrative: March 20 2021 (shortly after 2nd Pfizer COVID19 vaccine March 17 2021, injected into LEFT arm): woke up with burning, throbbing, RIGHT neck, shoulder, RIGHT  arm pain for 3-4 hours -- > numbness/tingling RIGHT shoulder to fingertips; dysesthesias to extremes of temperature in RIGHT arm; RIGHT hand>arm weakness and dexterity issues; dizziness with fast lateral movements that occurred a little bit later Pain went away in a few days, but still has residual numbness and tingling (even now) Dysesthesias to temperature lasted a few weeks   -- > MRI brain noncontrast March 29 2021 showed lesions c/f MS in the supra and infratentorium   -March 30 2021: L'hermitte's sign (shock or vibration) from abdomen to feet when looking down -- > steroids not given initially, as sx on neuro exam felt to be mild   -- > MRI C/T spine April 21 2021 with RIGHT C2-C3 nonenhancing lesion; repeat brain showed no enhancement -- > ACE slightly elevated; CT chest without LAN -- > April 23 2021 decided to order IV steroids given mild RIGHT hand weakness, given April 27-29 2021 -- helped, but still has numbness and tingling; it's getting easier to write and use a pipetter, but still some difficulty  IMPRESSION: This is a 26 Y man with CIS, one neurological event mostly causing RIGHT hand weakness and sensory sx plus vertigo that happened 3 days after a 2nd COVID19 vaccine.  He meets criteria for dissemination in space (spine, brainstem, and PV lesions) but does not meet dissemination in time (no contrast enhancing lesions, no change in brain lesions over 1 month of monitoring).  A LP is required to finalized criteria to discriminate between CIS and RRMS. Elevated ACE and ANA are common to see in MS, and I do not think they point to further pathology.
Age: 26.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Angiotensin converting enzyme increased, Arthralgia, CSF oligoclonal band present, Central nervous system lesion, Cerebral calcification
Clinical narrative: March 20 2021 (shortly after 2nd Pfizer COVID19 vaccine March 17 2021, injected into LEFT arm): woke up with burning, throbbing, RIGHT neck, shoulder, RIGHT  arm pain for 3-4 hours -- > numbness/tingling RIGHT shoulder to fingertips; dysesthesias to extremes of temperature in RIGHT arm; RIGHT hand>arm weakness and dexterity issues; dizziness with fast lateral movements that occurred a little bit later Pain went away in a few days, but still has residual numbness and tingling (even now) Dysesthesias to temperature lasted a few weeks   -- > MRI brain noncontrast March 29 2021 showed lesions c/f MS in the supra and infratentorium   -March 30 2021: L'hermitte's sign (shock or vibration) from abdomen to feet when looking down -- > steroids not given initially, as sx on neuro exam felt to be mild   -- > MRI C/T spine April 21 2021 with RIGHT C2-C3 nonenhancing lesion; repeat brain showed no enhancement -- > ACE slightly elevated; CT chest without LAN -- > April 23 2021 decided to order IV steroids given mild RIGHT hand weakness, given April 27-29 2021 -- helped, but still has numbness and tingling; it's getting easier to write and use a pipetter, but still some difficulty  IMPRESSION: This is a 26 Y man with CIS, one neurological event mostly causing RIGHT hand weakness and sensory sx plus vertigo that happened 3 days after a 2nd COVID19 vaccine.  He meets criteria for dissemination in space (spine, brainstem, and PV lesions) but does not meet dissemination in time (no contrast enhancing lesions, no change in brain lesions over 1 month of monitoring).  A LP is required to finalized criteria to discriminate between CIS and RRMS. Elevated ACE and ANA are common to see in MS, and I do not think they point to further pathology.
Age: 26.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Clinically isolated syndrome, Computerised tomogram spine, Computerised tomogram thorax, Dizziness, Dysaesthesia
Clinical narrative: March 20 2021 (shortly after 2nd Pfizer COVID19 vaccine March 17 2021, injected into LEFT arm): woke up with burning, throbbing, RIGHT neck, shoulder, RIGHT  arm pain for 3-4 hours -- > numbness/tingling RIGHT shoulder to fingertips; dysesthesias to extremes of temperature in RIGHT arm; RIGHT hand>arm weakness and dexterity issues; dizziness with fast lateral movements that occurred a little bit later Pain went away in a few days, but still has residual numbness and tingling (even now) Dysesthesias to temperature lasted a few weeks   -- > MRI brain noncontrast March 29 2021 showed lesions c/f MS in the supra and infratentorium   -March 30 2021: L'hermitte's sign (shock or vibration) from abdomen to feet when looking down -- > steroids not given initially, as sx on neuro exam felt to be mild   -- > MRI C/T spine April 21 2021 with RIGHT C2-C3 nonenhancing lesion; repeat brain showed no enhancement -- > ACE slightly elevated; CT chest without LAN -- > April 23 2021 decided to order IV steroids given mild RIGHT hand weakness, given April 27-29 2021 -- helped, but still has numbness and tingling; it's getting easier to write and use a pipetter, but still some difficulty  IMPRESSION: This is a 26 Y man with CIS, one neurological event mostly causing RIGHT hand weakness and sensory sx plus vertigo that happened 3 days after a 2nd COVID19 vaccine.  He meets criteria for dissemination in space (spine, brainstem, and PV lesions) but does not meet dissemination in time (no contrast enhancing lesions, no change in brain lesions over 1 month of monitoring).  A LP is required to finalized criteria to discriminate between CIS and RRMS. Elevated ACE and ANA are common to see in MS, and I do not think they point to further pathology.
Age: 26.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Electric shock sensation, Fine motor skill dysfunction, Hypoaesthesia, Intervertebral disc disorder, Magnetic resonance imaging head abnormal
Clinical narrative: March 20 2021 (shortly after 2nd Pfizer COVID19 vaccine March 17 2021, injected into LEFT arm): woke up with burning, throbbing, RIGHT neck, shoulder, RIGHT  arm pain for 3-4 hours -- > numbness/tingling RIGHT shoulder to fingertips; dysesthesias to extremes of temperature in RIGHT arm; RIGHT hand>arm weakness and dexterity issues; dizziness with fast lateral movements that occurred a little bit later Pain went away in a few days, but still has residual numbness and tingling (even now) Dysesthesias to temperature lasted a few weeks   -- > MRI brain noncontrast March 29 2021 showed lesions c/f MS in the supra and infratentorium   -March 30 2021: L'hermitte's sign (shock or vibration) from abdomen to feet when looking down -- > steroids not given initially, as sx on neuro exam felt to be mild   -- > MRI C/T spine April 21 2021 with RIGHT C2-C3 nonenhancing lesion; repeat brain showed no enhancement -- > ACE slightly elevated; CT chest without LAN -- > April 23 2021 decided to order IV steroids given mild RIGHT hand weakness, given April 27-29 2021 -- helped, but still has numbness and tingling; it's getting easier to write and use a pipetter, but still some difficulty  IMPRESSION: This is a 26 Y man with CIS, one neurological event mostly causing RIGHT hand weakness and sensory sx plus vertigo that happened 3 days after a 2nd COVID19 vaccine.  He meets criteria for dissemination in space (spine, brainstem, and PV lesions) but does not meet dissemination in time (no contrast enhancing lesions, no change in brain lesions over 1 month of monitoring).  A LP is required to finalized criteria to discriminate between CIS and RRMS. Elevated ACE and ANA are common to see in MS, and I do not think they point to further pathology.
Age: 26.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging spinal abnormal, Magnetic resonance imaging thoracic, Movement disorder, Muscular weakness, Neck pain
Clinical narrative: March 20 2021 (shortly after 2nd Pfizer COVID19 vaccine March 17 2021, injected into LEFT arm): woke up with burning, throbbing, RIGHT neck, shoulder, RIGHT  arm pain for 3-4 hours -- > numbness/tingling RIGHT shoulder to fingertips; dysesthesias to extremes of temperature in RIGHT arm; RIGHT hand>arm weakness and dexterity issues; dizziness with fast lateral movements that occurred a little bit later Pain went away in a few days, but still has residual numbness and tingling (even now) Dysesthesias to temperature lasted a few weeks   -- > MRI brain noncontrast March 29 2021 showed lesions c/f MS in the supra and infratentorium   -March 30 2021: L'hermitte's sign (shock or vibration) from abdomen to feet when looking down -- > steroids not given initially, as sx on neuro exam felt to be mild   -- > MRI C/T spine April 21 2021 with RIGHT C2-C3 nonenhancing lesion; repeat brain showed no enhancement -- > ACE slightly elevated; CT chest without LAN -- > April 23 2021 decided to order IV steroids given mild RIGHT hand weakness, given April 27-29 2021 -- helped, but still has numbness and tingling; it's getting easier to write and use a pipetter, but still some difficulty  IMPRESSION: This is a 26 Y man with CIS, one neurological event mostly causing RIGHT hand weakness and sensory sx plus vertigo that happened 3 days after a 2nd COVID19 vaccine.  He meets criteria for dissemination in space (spine, brainstem, and PV lesions) but does not meet dissemination in time (no contrast enhancing lesions, no change in brain lesions over 1 month of monitoring).  A LP is required to finalized criteria to discriminate between CIS and RRMS. Elevated ACE and ANA are common to see in MS, and I do not think they point to further pathology.
Age: 26.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Neurological examination abnormal, Neurological symptom, Pain, Pain in extremity, Paraesthesia
Clinical narrative: March 20 2021 (shortly after 2nd Pfizer COVID19 vaccine March 17 2021, injected into LEFT arm): woke up with burning, throbbing, RIGHT neck, shoulder, RIGHT  arm pain for 3-4 hours -- > numbness/tingling RIGHT shoulder to fingertips; dysesthesias to extremes of temperature in RIGHT arm; RIGHT hand>arm weakness and dexterity issues; dizziness with fast lateral movements that occurred a little bit later Pain went away in a few days, but still has residual numbness and tingling (even now) Dysesthesias to temperature lasted a few weeks   -- > MRI brain noncontrast March 29 2021 showed lesions c/f MS in the supra and infratentorium   -March 30 2021: L'hermitte's sign (shock or vibration) from abdomen to feet when looking down -- > steroids not given initially, as sx on neuro exam felt to be mild   -- > MRI C/T spine April 21 2021 with RIGHT C2-C3 nonenhancing lesion; repeat brain showed no enhancement -- > ACE slightly elevated; CT chest without LAN -- > April 23 2021 decided to order IV steroids given mild RIGHT hand weakness, given April 27-29 2021 -- helped, but still has numbness and tingling; it's getting easier to write and use a pipetter, but still some difficulty  IMPRESSION: This is a 26 Y man with CIS, one neurological event mostly causing RIGHT hand weakness and sensory sx plus vertigo that happened 3 days after a 2nd COVID19 vaccine.  He meets criteria for dissemination in space (spine, brainstem, and PV lesions) but does not meet dissemination in time (no contrast enhancing lesions, no change in brain lesions over 1 month of monitoring).  A LP is required to finalized criteria to discriminate between CIS and RRMS. Elevated ACE and ANA are common to see in MS, and I do not think they point to further pathology.
Age: 26.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Relapsing-remitting multiple sclerosis, Scan with contrast abnormal, Vertigo, Vitamin D, White matter lesion
Clinical narrative: March 20 2021 (shortly after 2nd Pfizer COVID19 vaccine March 17 2021, injected into LEFT arm): woke up with burning, throbbing, RIGHT neck, shoulder, RIGHT  arm pain for 3-4 hours -- > numbness/tingling RIGHT shoulder to fingertips; dysesthesias to extremes of temperature in RIGHT arm; RIGHT hand>arm weakness and dexterity issues; dizziness with fast lateral movements that occurred a little bit later Pain went away in a few days, but still has residual numbness and tingling (even now) Dysesthesias to temperature lasted a few weeks   -- > MRI brain noncontrast March 29 2021 showed lesions c/f MS in the supra and infratentorium   -March 30 2021: L'hermitte's sign (shock or vibration) from abdomen to feet when looking down -- > steroids not given initially, as sx on neuro exam felt to be mild   -- > MRI C/T spine April 21 2021 with RIGHT C2-C3 nonenhancing lesion; repeat brain showed no enhancement -- > ACE slightly elevated; CT chest without LAN -- > April 23 2021 decided to order IV steroids given mild RIGHT hand weakness, given April 27-29 2021 -- helped, but still has numbness and tingling; it's getting easier to write and use a pipetter, but still some difficulty  IMPRESSION: This is a 26 Y man with CIS, one neurological event mostly causing RIGHT hand weakness and sensory sx plus vertigo that happened 3 days after a 2nd COVID19 vaccine.  He meets criteria for dissemination in space (spine, brainstem, and PV lesions) but does not meet dissemination in time (no contrast enhancing lesions, no change in brain lesions over 1 month of monitoring).  A LP is required to finalized criteria to discriminate between CIS and RRMS. Elevated ACE and ANA are common to see in MS, and I do not think they point to further pathology.
Age: 24.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lip blister, Swollen tongue, Tongue blistering
Clinical narrative: Less than 24 hours tongue swelled so bad could not close the mouth. Blisters on tongue and inside the mouth and lips.; Less than 24 hours tongue swelled so bad could not close the mouth. Blisters on tongue and inside the mouth and lips.; Less than 24 hours tongue swelled so bad could not close the mouth. Blisters on tongue and inside the mouth and lips.; Less than 24 hours tongue swelled so bad could not close the mouth. Blisters on tongue and inside the mouth and lips.; This is a spontaneous report from a contactable consumer (patient). A 24-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration administered in left arm on 20Mar2021 15:00 (Batch/Lot number was not reported) (at the age of 24-year-old) as DOSE 1, SINGLE for covid-19 immunisation. The patient had no covid prior vaccination and was not covid tested post vaccination. The patient had no other vaccine in four weeks. The patient had no relevant medical history and no known allergies. The patient's concomitant medications were not reported. On 21Mar2021 at 06:00 AM, the patient experienced "less than 24 hours tongue swelled so bad could not close the mouth. Blisters on tongue and inside the mouth and lips." The events resulted in emergency room/department or urgent care. Therapeutic measures were taken as a result of events which included heavy dose of Benadryl for 36 hours. On an unspecified date, the events were recovered with sequelae (reported as recovered with lasting effects).  Information on the lot/batch number has been requested.
Age: 24.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lip blister, Oral mucosal blistering, Swollen tongue, Tongue blistering
Clinical narrative: Less than 24 hours tongue swelled so bad could not close the mouth. Blisters on tongue and inside the mouth and lips.; Less than 24 hours tongue swelled so bad could not close the mouth. Blisters on tongue and inside the mouth and lips.; Less than 24 hours tongue swelled so bad could not close the mouth. Blisters on tongue and inside the mouth and lips.; Less than 24 hours tongue swelled so bad could not close the mouth. Blisters on tongue and inside the mouth and lips.; This is a spontaneous report from a contactable consumer (patient). A 24-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration administered in left arm on 20Mar2021 15:00 (Batch/Lot number was not reported) (at the age of 24-year-old) as DOSE 1, SINGLE for covid-19 immunisation. The patient had no covid prior vaccination and was not covid tested post vaccination. The patient had no other vaccine in four weeks. The patient had no relevant medical history and no known allergies. The patient's concomitant medications were not reported. On 21Mar2021 at 06:00 AM, the patient experienced "less than 24 hours tongue swelled so bad could not close the mouth. Blisters on tongue and inside the mouth and lips." The events resulted in emergency room/department or urgent care. Therapeutic measures were taken as a result of events which included heavy dose of Benadryl for 36 hours. On an unspecified date, the events were recovered with sequelae (reported as recovered with lasting effects).  Information on the lot/batch number has been requested.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chills, Dyspnoea
Clinical narrative: Immediate onset of chills (short duration), shortened intake of breath (could not draw a full breath).  Waited 20 minutes to determine if I was having an anxiety reaction w/ breathing.  Labored breathing persisted.  Went to ER where they did the intake, took x-rays.  Waited a few hours in an exam room.  Breathing eventually relaxed.  The ER doctor said my x-ray looked like I had emphysema, but all the other indicators (blood test, blood pressure, etc.) were normal.  I never smoked and there is no family history.  I surmised it was due to the fact that I was gasping and trying to draw in more air since the onset.  I would have to yawn or cough to exhale comfortably.  I went home after the test results, but the symptoms would wax and wane.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Agitation, Anxiety, Blood test, Chest X-ray, Chest discomfort
Clinical narrative: Immediate onset of chills (short duration), shortened intake of breath (could not draw a full breath).  Waited 20 minutes to determine if I was having an anxiety reaction w/ breathing.  Labored breathing persisted.  Went to ER where they did the intake, took x-rays.  Waited a few hours in an exam room.  Breathing eventually relaxed.  The ER doctor said my x-ray looked like I had emphysema, but all the other indicators (blood test, blood pressure, etc.) were normal.  I never smoked and there is no family history.  I surmised it was due to the fact that I was gasping and trying to draw in more air since the onset.  I would have to yawn or cough to exhale comfortably.  I went home after the test results, but the symptoms would wax and wane.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chills, Cough, Dyspnoea, Electrocardiogram, Emphysema
Clinical narrative: Immediate onset of chills (short duration), shortened intake of breath (could not draw a full breath).  Waited 20 minutes to determine if I was having an anxiety reaction w/ breathing.  Labored breathing persisted.  Went to ER where they did the intake, took x-rays.  Waited a few hours in an exam room.  Breathing eventually relaxed.  The ER doctor said my x-ray looked like I had emphysema, but all the other indicators (blood test, blood pressure, etc.) were normal.  I never smoked and there is no family history.  I surmised it was due to the fact that I was gasping and trying to draw in more air since the onset.  I would have to yawn or cough to exhale comfortably.  I went home after the test results, but the symptoms would wax and wane.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hypersensitivity, Hypopnoea, Influenza, Investigation, Oropharyngeal pain
Clinical narrative: Immediate onset of chills (short duration), shortened intake of breath (could not draw a full breath).  Waited 20 minutes to determine if I was having an anxiety reaction w/ breathing.  Labored breathing persisted.  Went to ER where they did the intake, took x-rays.  Waited a few hours in an exam room.  Breathing eventually relaxed.  The ER doctor said my x-ray looked like I had emphysema, but all the other indicators (blood test, blood pressure, etc.) were normal.  I never smoked and there is no family history.  I surmised it was due to the fact that I was gasping and trying to draw in more air since the onset.  I would have to yawn or cough to exhale comfortably.  I went home after the test results, but the symptoms would wax and wane.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pulmonary function test, SARS-CoV-2 test, Vital signs measurement, Wheezing
Clinical narrative: Immediate onset of chills (short duration), shortened intake of breath (could not draw a full breath).  Waited 20 minutes to determine if I was having an anxiety reaction w/ breathing.  Labored breathing persisted.  Went to ER where they did the intake, took x-rays.  Waited a few hours in an exam room.  Breathing eventually relaxed.  The ER doctor said my x-ray looked like I had emphysema, but all the other indicators (blood test, blood pressure, etc.) were normal.  I never smoked and there is no family history.  I surmised it was due to the fact that I was gasping and trying to draw in more air since the onset.  I would have to yawn or cough to exhale comfortably.  I went home after the test results, but the symptoms would wax and wane.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood pressure normal, Blood test normal, Chest X-ray abnormal, Chills, Dyspnoea
Clinical narrative: Immediate onset of chills (short duration), shortened intake of breath (could not draw a full breath).  Waited 20 minutes to determine if I was having an anxiety reaction w/ breathing.  Labored breathing persisted.  Went to ER where they did the intake, took x-rays.  Waited a few hours in an exam room.  Breathing eventually relaxed.  The ER doctor said my x-ray looked like I had emphysema, but all the other indicators (blood test, blood pressure, etc.) were normal.  I never smoked and there is no family history.  I surmised it was due to the fact that I was gasping and trying to draw in more air since the onset.  I would have to yawn or cough to exhale comfortably.  I went home after the test results, but the symptoms would wax and wane.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Immediate post-injection reaction
Clinical narrative: Immediate onset of chills (short duration), shortened intake of breath (could not draw a full breath).  Waited 20 minutes to determine if I was having an anxiety reaction w/ breathing.  Labored breathing persisted.  Went to ER where they did the intake, took x-rays.  Waited a few hours in an exam room.  Breathing eventually relaxed.  The ER doctor said my x-ray looked like I had emphysema, but all the other indicators (blood test, blood pressure, etc.) were normal.  I never smoked and there is no family history.  I surmised it was due to the fact that I was gasping and trying to draw in more air since the onset.  I would have to yawn or cough to exhale comfortably.  I went home after the test results, but the symptoms would wax and wane.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Pruritus, Urticaria
Clinical narrative: All over body itching for 12 hours; Three hives; Right wrist had a deep red line beneath the skin the climbed to about 3 inches; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration on 16Apr2021 at 11:30 (at the age of 48-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. Concomitant medications included sertraline hydrochloride (ZOLOFT) 150 mg and natures way alive vitamins both started from an unknown date, for an unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021 at 11:45 the patient experienced all over body itching for 12 hours, three hives and right wrist had a deep red line beneath the skin the climbed to about 3 inches. The clinical outcome of the events all over body itching for 12 hours, three hives and right wrist had a deep red line beneath the skin the climbed to about 3 inches was recovered on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.